Spectrometric techniques for diagnosis of breast cancer

Breast cancer comprises 22.9% of invasive cancers in women and 16% of all female cancers. Diagnosing breast cancer in early stage itself has a greater effect on the prognosis. Nowadays FES and FTIR are tremendously used for biomedical applications in diagnosis of tissues and blood samples. In the present work FTIR and Fluorescence emission spectrum of extracted biomolecules from the blood samples of different stages of breast cancer subjects are analyzed. Autofluoroscence Intensity of NADH, Flavin, Porphyrin Endofluorophores peak are clearly differentiating the different stages of breast cancer blood samples. Five absorbance peaks of FTIR spectrum are also distinguishing cancer subjects from normal spectra.